ClinicalTrials.gg
Not yet recruitingNCT06820437Updated Feb 11, 2025

Comparison of the Effectiveness of High Fidelity Simulation and Low Fidelity Simulation in Active External Bleeding Control Management of Caregivers of Elderly Individuals

An observational study in Simulation Training, High Fidelity Simulation Training and First Aid, sponsored by Mustafa Kemal University. Not yet recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-11.

Sponsored by Mustafa Kemal University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

The elderly population is increasing worldwide. Due to the increase in the elderly population, emergencies related to ageing are also encountered more frequently. One of these emergencies is trauma in the elderly. Traumas are frequently seen in elderly individuals due to physiological deficiencies related to aging as well as environmental factors. External bleeding caused by trauma is also encountered. If first aid to stop active external bleeding is not administered in a timely and correct manner, death due to bleeding can occur. Nowadays, elderly individuals live either with their families, alone, or in institutions. In the event of external bleeding, either the individual themselves, caregiving family members, or staff at the institution should be able to perform first aid to stop the bleeding.

Elderly individuals may not be able to perform first aid due to cognitive and neurological deficiencies. The ability of caregivers to provide first aid can be life-saving. If caregivers of elderly individuals are trained in first aid for external bleeding, they can quickly and correctly administer first aid to stop the bleeding. First aid training often consists of didactic education and demonstrations. A training strategy that ensures knowledge retention and skill acquisition is simulation training. This study aims to evaluate and compare the effectiveness of high-fidelity simulation and low-fidelity (Visually Enhanced Mental Simulation - VEMS) simulation in the skills of caregivers for elderly individuals in managing active external bleeding control.

The population of the study will consist of non-health professional caregivers of elderly individuals living in Antakya district of Hatay province. The sample size, calculated using the G Power program, has been determined to include 30 caregivers of elderly individuals. The study consists of four main work packages. In the first stage, the simulation environment will be prepared, and in the second stage, a preliminary application of the project will be conducted. In the third stage, the implementation of the research and the completion of checklists will be ensured. For this, volunteer caregivers of elderly individuals will be identified. After theoretical training is given to the participants, they will be assigned to intervention group 1 (VEMS) and intervention group 2 (high-fidelity simulation) using simple randomization. Following a pre-assessment with low-fidelity simulation, participants will undergo simulation training according to their intervention groups. Subsequently, a final assessment will be conducted using the same lowfidelity simulation. In the final stage, data analysis and interpretation of the findings will be carried out. The collected data will be analyzed statistically, and the significance level will be accepted as p\<0.05. With this study, insight will be provided into the effectiveness of VEMS and high-fidelity simulation in first aid training for active external bleeding for caregivers of elderly individuals. On the other hand, it is planned that the project results will be published in at least one article in journals indexed in the SSCI Expanded.

02

Conditions studied

  • Simulation Training
  • High Fidelity Simulation Training
  • First Aid
  • Informal Caregivers
  • Elderly
  • Bleeding

Browse trials for

Keywords

  • Elderly caregivers
  • external bleeding
  • elderly
  • first aid training
  • simulation
  • visually enhanced mental simulation
  • high fidelity simulation
03

In context

Hemorrhage

3,011 studies on the registry are indexed under Hemorrhage; 466 are open to participants now.

This study's planned enrollment of 30 is below the median of 150 across 897 observational studies indexed under Hemorrhage.

Browse Hemorrhage studies →

Lead sponsor

Mustafa Kemal University is the lead sponsor of 75 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The population of the study will consist of non-health professional caregivers of elderly individuals living in Antakya district of Hatay province. The sample size was determined by calculating in the G Power program. With 95% confidence (1-α), 95% test power (1-β), d=1.387 effect size and two-way independent samples t-test, the number of samples to be taken in each group was determined as 15 (Scalese et al., 2022). After the theoretical training, participants will be randomly assigned to groups by lottery method. With the support of neighborhood mukhtars, individuals who care for elderly individuals will be contacted and informed about the study, and volunteer caregivers who are not health professionals will be included in the study by signing informed consent.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Not having received the theoretical first assessment and first aid training in external bleeding
  • No cognitive and communication problems that can actively participate in the study
  • Not being a health professional
  • Not being a paid caregiver

Exclusion criteria

Exclusion Criteria:

  • The participant declares that he/she wants to leave at any stage of the study
  • Not participating in any of the simulation phases
  • Not participating in the implementation of the data collection tools to be applied
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Intervention group 1:

    VEMS (low-fidelity simulation)

    Other: Low-fidelity (Visually Enhanced Mental Simulation-VEMS) simulation training

  • Intervention group 2

    High-fidelity (simulated patient/standard patient) simulation

    Other: High-fidelity (simulated patient/standard patient) simulation training

Interventions

  • OtherLow-fidelity (Visually Enhanced Mental Simulation-VEMS) simulation training

    Intervention group 1: Low-fidelity (Visually Enhanced Mental Simulation-VEMS) simulation training will be conducted on active external bleeding control management skills of caregivers of elderly individuals. In this intervention poster and cards will be used.

  • OtherHigh-fidelity (simulated patient/standard patient) simulation training

    Intervention group 2: High-fidelity (simulated patient/standard patient) simulation training will be conducted for caregivers of elderly individuals in active external bleeding control management skills. Standardized patient who will act as elderly will be used in this intervention.

06

What researchers measure

Primary outcomes

  1. Active external bleeding control management skills of caregivers of elderly individuals assesed by "Active External Bleeding Management Asssesment Form"

    Active External Bleeding Management Asssesment Form was developed by the researchers. It includes 13 items which evaluate first aid inteventions for external bleeding. Expert opininons were taken for content validity of the form.

    Time frame: 1st - 4 th months

Secondary outcomes

  1. Obtaining the opinions of caregivers of elderly individuals on the interventions by using Simulation Assesment Form

    The opinions of the caregivers of elderly individuals about the interventions, which are high fidelity simulation and low fidelity simulation in active external bleeding control management skills, will be obtained through questionnaires developed by the researchers in the light of the literature by taking expert opinion. The form includes likert type 12 items.

    Time frame: 1st-4th months

07

Study locations

2 sites
  • Hatay Mustafa Kemal University
    Hatay, Antakya 31001, Turkey (Türkiye)
  • Hatay Mustafa Kemal University
    Antakya, Hatay 31001, Turkey (Türkiye)
08

References and documents

Publications

  • Abou-Raya S, ElMeguid LA. Road traffic accidents and the elderly. Geriatr Gerontol Int. 2009 Sep;9(3):290-7. doi: 10.1111/j.1447-0594.2009.00535.x. PubMed 19702940 ↗
  • Abatzis VT, Littlewood KE. Debriefing in Simulation and Beyond. Int Anesthesiol Clin. 2015 Fall;53(4):151-62. doi: 10.1097/AIA.0000000000000070. PubMed 26397791 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2025; primary completion for Jun 2025, 4 months later.

Of 339 non-industry observational studies under Hemorrhage, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 57. This study's planned 4 months is below that.

Counting every sponsor, half of 364 studies reached it within 30 months; a quarter within 14 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2025
First posted
Feb 11, 2025
StartEst.
Feb 20, 2025
Primary completionEst.
Jun 20, 2025
CompletionEst.
Aug 20, 2025
Last update
Feb 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06820437
Lead sponsor
Mustafa Kemal University
Responsible party
Songül Demir (Doctorate Student- Lecturer, Mustafa Kemal University) — Principal investigator
First posted
Feb 11, 2025
Start date
Feb 20, 2025 (estimated)
Primary completion
Jun 20, 2025 (estimated)
Completion
Aug 20, 2025 (estimated)
Last update
Feb 11, 2025

Study contacts

Songül Demir
Contact
prmsongul@gmail.com
+90 0 505 571 86 71
Zahide Tunçbilek
Contact
ztuna@hacettepe.edu.tr
+90 0312 305 15 80 ext. 185

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion